These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 660653)

  • 21. Somatic mutation creates diversity in the major group of mouse immunoglobulin kappa light chains.
    Heinrich G; Traunecker A; Tonegawa S
    J Exp Med; 1984 Feb; 159(2):417-35. PubMed ID: 6420501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-315).
    Dugan ES; Bradshaw RA; Simms ES; Eisen HN
    Biochemistry; 1973 Dec; 12(26):5400-16. PubMed ID: 4760498
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular characterization of a nonsecreting myeloma mutant.
    Argon Y; Burrone OR; Milstein C
    Eur J Immunol; 1983 Apr; 13(4):301-5. PubMed ID: 6406235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Karyotype changes of KG-13 plasmacytoma after heterotransplantation].
    Wieser O; Emminger A; Mohr U
    Z Krebsforsch; 1967; 69(1):19-24. PubMed ID: 4230987
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental plasmacytoma in mice. II. Qualitative studies of myeloma proteins.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):131-6. PubMed ID: 7283675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The arrangement and rearrangement of antibody genes.
    Seidman JG; Leder P
    Nature; 1978 Dec 21-28; 276(5690):790-5. PubMed ID: 103004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence analysis of immunoglobulin light chain messenger RNA.
    Milstein C; Brownlee GG; Cartwright EM; Jarvis JM; Proudfoot NJ
    Nature; 1974 Nov; 252(5482):354-9. PubMed ID: 4473725
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequences of mouse immunoglobulin light chain genes before and after somatic changes.
    Bernard O; Hozumi N; Tonegawa S
    Cell; 1978 Dec; 15(4):1133-44. PubMed ID: 103630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of the deletion of chromosome No. 15 in mouse plasmacytoma: brief communication.
    Yoshida MC; Moriwaki K; Migita S
    J Natl Cancer Inst; 1978 Jan; 60(1):235-8. PubMed ID: 628020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.
    Stanton LW; Watt R; Marcu KB
    Nature; 1983 Jun 2-8; 303(5916):401-6. PubMed ID: 6304522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mouse models for hematopoietic tumorigenesis.
    Harris AW; Langdon WY; Alexander WS; Hariharan IK; Rosenbaum H; Vaux D; Webb E; Bernard O; Crawford M; Abud H
    Curr Top Microbiol Immunol; 1988; 141():82-93. PubMed ID: 3215058
    [No Abstract]   [Full Text] [Related]  

  • 32. Intervening sequences divide the gene for the constant region of mouse immunoglobulin mu chains into segments, each encoding a domain.
    Gough NM; Kemp DJ; Tyler BM; Adams JM; Cory S
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):554-8. PubMed ID: 6767239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloma based expression system for production of large mammalian proteins.
    Traunecker A; Oliveri F; Karjalainen K
    Trends Biotechnol; 1991 Apr; 9(4):109-13. PubMed ID: 1367388
    [No Abstract]   [Full Text] [Related]  

  • 34. [Enzymatic synthesis of the structural gene of MORC-21 myeloma immunoglobulin light chains].
    Deev SM; Barkabar' NI; Karlyshev AV; Grechko VV; Polianovskiĭ OL
    Dokl Akad Nauk SSSR; 1979; 248(2):469-71. PubMed ID: 90593
    [No Abstract]   [Full Text] [Related]  

  • 35. Karyotypic evolution associated with loss of tumorigenicity.
    Shepard JS; Pettengill OS; Wurster-Hill DH; Sorenson GD
    J Natl Cancer Inst; 1979 Mar; 62(3):547-54. PubMed ID: 283284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide sequence of the cDNAs encoding the variable region heavy and light chains of a myeloma protein specific for the terminal nonreducing end of alpha(1----6)dextran.
    Borden P; Kabat EA
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2440-3. PubMed ID: 2436230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin V/J recombination is accompanied by deletion of joining site and variable region segments.
    Seidman JG; Nau MM; Norman B; Kwan SP; Scharff M; Leder P
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6022-6. PubMed ID: 6777777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-binding mutants of mouse myeloma cells.
    Cook WD; Scharff MD
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5687-91. PubMed ID: 271995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA sequence associated with chromosome translocations in mouse plasmacytomas.
    Harris LJ; D'Eustachio P; Ruddle FH; Marcu KB
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6622-6. PubMed ID: 6959142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo sister chromatid exchange analysis of a mouse plasmacytoma cell line NP-38.
    Kanda N; Moriwaki K
    Exp Cell Res; 1983 Jul; 146(2):417-21. PubMed ID: 6873197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.